Health ❯ Public Health ❯ Substance Abuse
Fentanyl Fentanyl Overdoses Overdose Deaths Fentanyl Overdose Addiction Treatment Fentanyl Crisis Addiction Fentanyl Addiction Fentanyl Overdose Crisis Naloxone Distribution Overdoses Prescription Drug Misuse Synthetic Drugs Senior Overdose Deaths Opioid Settlements Medical Training Health Policy Synthetic Opioids Overdose Incidents Mass Overdose Crisis Management Health Statistics Legal Accountability Alameda County Opioid Crisis Health Crisis Management Ohio Naloxone Pregnancy and Substance Use Social Impact Mitigation Strategies Drug Overdose Mortality Rates Prevention Strategies Naloxone Access Harm Reduction Drug Overdose Prevention Community Response Treatment Strategies Naloxone Awareness Naloxone Accessibility Impact on Society Community Grants Prescription Drug Abuse OxyContin Crisis Response
Want to see what podcasts are saying about this topic? Search across 125K+ podcasts. Explore Radar
The agency says the move will target concentrated and lab‑made 7‑hydroxymitragynine products because regulators link them to rising poisonings and local overdose deaths.
